After studying my bachelor's degree in Biomedical Sciences at Universitat de Barcelona, I pursued the master's programme in Translational Biomedical Research at the Vall d'Hebron Institute of Research (VHIR), aiming to direct my professional career to the clinical field. Due to my interest in gynaecology, I carried out its curricular internship in the Biomedical Research in Gynaecology group, developing the project “Study of Phototrexate as a possible therapeutic agent for endometrial cancer”.

The sponsorship of the "Mocador Solidari" initiative, promoted by Vall d'Hebron with the collaboration of Natura and Judit Mascó as its ambassador, allowed me to join the group as a phD student under the supervision of Dr. Eva Colás. Within this project I am currently working to develop new therapeutic strategies for improving the treatment of endometrial cancer. This cancer is the most common gynaecologic malignancy, accounting for 6% of diagnosed cancers in women. More specifically, we are studying the efficacy of the combination of immunotherapy with the ABTL0812 molecule, which has previously demonstrated good results in this type of cancer. This could specially improve the therapeutic options of patients with aggressive subtypes of endometrial cancer.

Simultaneously, I also collaborate with the clinical team of the hospital's Gynaecology Service to analyse, understand, and work on the molecular profile of patients with endometriosis. We aim to progress and individualize their clinical management, regarding both the diagnostic process and therapeutic options, to improve the quality of life of those patients.